Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systemic lupus erythematosus.

Daniel J Wallace1

  • 1Clinical Professor of Medicine, UCLA School of Medicine, Los Angeles, CA 90048, USA. dwallacea@ucla.edu

Drugs of Today (Barcelona, Spain : 1998)
|January 18, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical utility of a multianalyte lupus risk score incorporating cell-bound complement activation products: a systematic evaluation.

Lupus science & medicine·2026
Same author

Bias due to interval censored outcomes in a study of flare risk after hydroxychloroquine taper/cessation in systemic lupus erythematosus.

Journal of clinical epidemiology·2026
Same author

Defining Optimally Safe and Effective Blood Levels of Hydroxychloroquine in Lupus: An Important Step Toward Precision Drug Monitoring.

Arthritis & rheumatology (Hoboken, N.J.)·2025
Same author

Clinical Practice Guideline for Evaluation and Management of Peripheral Nervous System Manifestations in Sjögren's Disease.

Arthritis care & research·2025
Same author

Dysregulated soluble immune mediators and lupus-associated autoantibody specificities inform the development of immune indexes that characterise classified SLE transition and SLE disease activity.

Lupus science & medicine·2025
Same author

2025 American College of Rheumatology (ACR) Guideline for the Treatment of Systemic Lupus Erythematosus.

Arthritis & rheumatology (Hoboken, N.J.)·2025

Systemic lupus erythematosus (SLE) is a complex autoimmune disease affecting the whole body. Advances in understanding its causes, prevention, and treatments like immunosuppressants and biologics are improving patient outlook and quality of life.

Area of Science:

  • Immunology
  • Rheumatology
  • Autoimmune Diseases

Background:

  • Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease with diverse clinical manifestations.
  • The exact etiology of SLE remains unknown, posing significant challenges in management.
  • SLE significantly impacts patient quality of life and prognosis.

Purpose of the Study:

  • To review recent advancements in understanding SLE pathogenesis.
  • To discuss the evolving landscape of SLE management strategies.
  • To highlight the impact of new therapies on patient outcomes.

Main Methods:

  • Literature review of recent studies on SLE.
  • Analysis of emerging data on SLE pathogenesis.
  • Evaluation of current and novel therapeutic approaches for SLE.

Related Experiment Videos

Main Results:

  • New insights into the pathogenesis of SLE are emerging.
  • Preventive measures and combination immunosuppressive therapies show promise.
  • Biologic agents are demonstrating efficacy in altering disease course.

Conclusions:

  • Advances in SLE research are leading to improved treatment strategies.
  • Novel therapies, including biologics, are transforming the prognosis for SLE patients.
  • Enhanced understanding and management are improving the quality of life for individuals with SLE.